Richard Davis added another duty at NMT Medical Inc. Wednesday, gaining a seat on the board of the Boston-based cardiac implant maker.
Davis, 51, was promoted to COO in February following the departure of former CEO John Ahern. Ahern’s replacement — initially on a temporary basis — was Frank Martin, 71, an NTM board member who in April signed on to permanently head the firm.
Davis was CFO at NMT for more than eight years before the promotion to COO, having joined the company in August 2000 from Argus Management Corp., an Boston-area consulting firm. He put in a short stint with a laser manufacturer before that and also spent 10 years in various financial and management roles at Framingham-based retailer TJX Cos. Inc.
Chairman James Mahoney Jr. cited Davis’ long tenure and broad knowledge of the company as factors in his selection to the NMT board.
NTM is conducting late-stage trials of its StarFlex implant, designed to close holes between the upper chambers of the heart, and is expecting a decision from U.S. regulators on the device in late 2010.
The NTM board had been briefly operating with only five members, down from its usual six, after James Lock decided in April not to seek re-election to the seat he had held since August 2000.